{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000345.3:c.91G>C",
          "cDNA Change": {
            "transcript": "NM_000345.3",
            "ref": "G",
            "alt": "C",
            "position": "91"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "P",
            "position": "30"
          },
          "Description in input context": "A30P mutation in a-synuclein"
        },
        {
          "HGVS": "NM_000345.3:c.157A>T",
          "cDNA Change": {
            "transcript": "NM_000345.3",
            "ref": "A",
            "alt": "T",
            "position": "157"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "A53T mutation in a-synuclein"
        },
        {
          "HGVS": "NM_000345.3:c.137G>A",
          "cDNA Change": {
            "transcript": "NM_000345.3",
            "ref": "G",
            "alt": "A",
            "position": "137"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "E",
            "position": "46"
          },
          "Description in input context": "E46K mutation in a-synuclein"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005261"
  },
  "Experiment Method": [
    {
      "Assay Method": "Cell culture with drug exposure",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "SH-SY5Y",
        "Description": "SH-SY5Y cells were transfected with plasmids expressing wild-type or mutant a-synuclein (A30P, A53T, E46K) and exposed to rotenone and maneb."
      },
      "Readout type": "Functional",
      "Readout description": [
        {
          "Variant": "NM_000345.3:c.91G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Loss-of-function",
          "Result Description": "A30P mutation abolished neuroprotective effects of a-synuclein under rotenone/maneb exposure."
        },
        {
          "Variant": "NM_000345.3:c.157A>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Loss-of-function",
          "Result Description": "A53T mutation abolished neuroprotective effects of a-synuclein under rotenone/maneb exposure."
        },
        {
          "Variant": "NM_000345.3:c.137G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Loss-of-function",
          "Result Description": "E46K mutation abolished neuroprotective effects of a-synuclein under rotenone/maneb exposure."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}